Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Clinical trial NCT02269293 · COMPLETED
Trial details
- NCT number
- NCT02269293
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-13
- Primary completion
- 2021-04-20
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.